Role of economic evidence in coverage decision-making in South Korea.

Eun-Young Bae Hui Jeong KimHye-Jae LeeJunho JangSeung Min LeeYunkyung JungNari YoonTae Kyung KimKookhee KimBong-Min Yang

Published in: PloS one (2018)

Cost-effectiveness is one of the most influential factors in drug-reimbursement decisions. However, inclusion of other explanatory variables, in addition to the cost-effectiveness ratio, predicted the results of decisions more accurately.

Keyphrases

affordable care act
healthcare
emergency department
adverse drug
health insurance